e-Drug3D

1067

CEFDINIR


INN
CEFDINIR

cas 91832-40-5
CLASS

ANTIINFECTIVES
ANTIBIOTIC
ANTIBACTERIAL
CEPHALOSPORINS
INHIBITION OF CELL WALL SYNTHESIS

ROUTE (list)

ORAL

ATC code

J01DD15

PK parameters

VD 22.75 LITER (65 KILOGRAM)
Cl 60 LITER / HOUR (65 KILOGRAM)
PPB 65 PERCENT
t1/2 1.7 HOUR

Solubility

SPARINGLY SOLUBLE IN WATER


Target

TARGET PENICILLIN-BINDING PROTEINS (PBPS)

DrugCentral

Bacterial penicillin-binding protein UNIPROT P02918 mrcA

Download SDF file (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Formula:
C14H13N5O5S2

Calculated chemical properties:

MW 394.43
NB_atoms 26
XLogP -1.51
PSA 144.657
NB_HD 4
NB_HA 10
fsp3 0.21
Lipinski(0=no;1=yes) 0

FDA
NDA 050739 (label) INN (CEFDINIR) OMNICEF (ABBVIE) APPROVAL= AP YEAR= 1997 NEWMOLECULARENTITY DISCONTINUED
NDA 050749 (label) INN (CEFDINIR) OMNICEF (ABBVIE) APPROVAL= AP YEAR= 1997 DISCONTINUED
NDA 065259 (pdf not found) INN (CEFDINIR) CEFDINIR (LUPIN) APPROVAL= AP YEAR= 2006
NDA 065264 (pdf not found) INN (CEFDINIR) CEFDINIR (LUPIN) APPROVAL= AP YEAR= 2006
NDA 065330 (pdf not found) INN (CEFDINIR) CEFDINIR (CHARTWELL RX) APPROVAL= AP YEAR= 2007
NDA 065332 (pdf not found) INN (CEFDINIR) CEFDINIR (TEVA PHARMS) APPROVAL= AP YEAR= 2007
NDA 065337 (pdf not found) INN (CEFDINIR) CEFDINIR (CHARTWELL RX) APPROVAL= AP YEAR= 2007
NDA 065368 (pdf not found) INN (CEFDINIR) CEFDINIR (TEVA PHARMS) APPROVAL= AP YEAR= 2007
NDA 065418 (pdf not found) INN (CEFDINIR) CEFDINIR (ANDA REPOSITORY) APPROVAL= AP YEAR= 2007
NDA 065429 (pdf not found) INN (CEFDINIR) CEFDINIR (ANDA REPOSITORY) APPROVAL= AP YEAR= 2007
NDA 065473 (pdf not found) INN (CEFDINIR) CEFDINIR (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2007
NDA 065434 (pdf not found) INN (CEFDINIR) CEFDINIR (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2008
NDA 210220 (pdf not found) INN (CEFDINIR) CEFDINIR (ALKEM LABS LTD) APPROVAL= AP YEAR= 2021
NDA 210534 (pdf not found) INN (CEFDINIR) CEFDINIR (ALKEM LABS LTD) APPROVAL= AP YEAR= 2021

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL